• LAST PRICE
    21.0700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    8.4300/ 2
  • Ask / Lots
    22.3500/ 5
  • Open / Previous Close
    --- / 21.0700
  • Day Range
    ---
  • 52 Week Range
    Low 15.3100
    High 26.8400
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 21.2
TimeVolumeXNCR
09:32 ET11105821.02
09:36 ET10021.15
09:38 ET10021.06
09:50 ET200020.935
09:52 ET10020.97
09:54 ET10021.035
09:56 ET160020.86
09:57 ET10020.895
09:59 ET70020.96
10:01 ET223421
10:03 ET50020.985
10:06 ET50020.995
10:10 ET231121.05
10:12 ET20021.02
10:15 ET71821.01
10:17 ET30021.06
10:19 ET60921.07
10:21 ET30021.03
10:26 ET83721.07
10:33 ET34221.061
10:35 ET84321.015
10:37 ET10020.99
10:39 ET158421.014
10:42 ET10021.03
10:44 ET10021.01
10:50 ET350021
10:51 ET120021.065
11:00 ET305721.035
11:04 ET180020.995
11:06 ET62421
11:08 ET40021
11:09 ET126320.91
11:11 ET420920.9325
11:13 ET81020.975
11:15 ET30021
11:18 ET40021
11:22 ET23921.0105
11:24 ET100021
11:26 ET60020.995
11:27 ET332821
11:29 ET40020.995
11:31 ET230421
11:33 ET304120.95
11:36 ET140020.99
11:38 ET90521.07
11:40 ET40021.14
11:42 ET50021.12
11:44 ET64021.21
11:45 ET50021.18
11:51 ET60021.15
11:54 ET40021.15
11:56 ET10021.16
11:58 ET40021.19
12:02 ET10021.195
12:05 ET10021.19
12:07 ET80021.17
12:09 ET10021.16
12:14 ET50021.14
12:16 ET110021.23
12:21 ET50021.23
12:23 ET11521.25
12:25 ET10021.25
12:30 ET50021.19
12:32 ET20021.16
12:36 ET30021.16
12:38 ET113521.155
12:43 ET20021.15
12:45 ET16121.155
12:48 ET10021.14
12:50 ET60021.16
12:52 ET20021.165
12:54 ET10021.18
12:56 ET40021.14
12:57 ET20021.13
12:59 ET310521.11
01:01 ET184621.04
01:03 ET50021.01
01:08 ET31921.01
01:10 ET181621.035
01:12 ET40021.05
01:14 ET56721.02
01:15 ET20021.02
01:17 ET20021.05
01:19 ET384521.02
01:21 ET92021.0175
01:24 ET180021
01:26 ET120020.975
01:28 ET30020.99
01:30 ET30020.96
01:32 ET120020.88
01:33 ET100020.94
01:35 ET10020.91
01:37 ET592121.03
01:39 ET290021.01
01:42 ET10021
01:44 ET21921.025
01:46 ET90021
01:48 ET20020.97
01:50 ET60020.94
01:51 ET30020.93
01:53 ET60020.95
01:55 ET20020.95
01:57 ET10020.95
02:00 ET41920.97
02:02 ET20020.96
02:04 ET110020.95
02:06 ET70020.91
02:08 ET63320.93
02:09 ET36520.935
02:11 ET42120.91
02:13 ET120020.95
02:15 ET10020.93
02:18 ET106820.93
02:20 ET50020.9
02:22 ET40020.915
02:24 ET20020.92
02:26 ET50020.89
02:27 ET40020.88
02:29 ET100020.88
02:31 ET120020.875
02:33 ET140020.88
02:36 ET10020.86
02:38 ET20020.86
02:40 ET50020.87
02:42 ET378220.88
02:44 ET30020.88
02:45 ET60020.89
02:47 ET161420.89
02:49 ET535420.925
02:51 ET121120.93
02:54 ET20020.92
02:56 ET515520.88
02:58 ET319920.97
03:00 ET120020.97
03:02 ET104120.95
03:03 ET119021
03:05 ET151020.9779
03:07 ET299421.04
03:09 ET99821.03
03:12 ET82321.005
03:14 ET205420.98
03:16 ET90020.97
03:18 ET345020.99
03:20 ET102721.05
03:21 ET10021.03
03:23 ET100021.05
03:25 ET20021.08
03:27 ET60621.1
03:30 ET40021.08
03:32 ET21321.09
03:34 ET60021.11
03:36 ET222921.1
03:38 ET158021.08
03:39 ET130021.1
03:41 ET294121.08
03:43 ET442221.11
03:45 ET90021.15
03:48 ET282721.1
03:50 ET70021.095
03:52 ET338321
03:54 ET1233521.04
03:56 ET501721.06
03:57 ET458021.05
03:59 ET80728221.07
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesXNCR
Xencor Inc
1.5B
-7.3x
---
United StatesARDX
Ardelyx Inc
1.4B
-22.0x
---
United StatesRCUS
Arcus Biosciences Inc
1.5B
-5.3x
---
United StatesDVAX
Dynavax Technologies Corp
1.5B
112.3x
---
United StatesTVTX
Travere Therapeutics Inc
1.2B
-3.0x
---
United StatesAUPH
Aurinia Pharmaceuticals Inc
1.0B
-20.5x
---
As of 2024-09-23

Company Information

Xencor, Inc. is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases. More than 20 candidates engineered with its XmAb technology are in clinical development, and three XmAb medicines are marketed by partners. Its XmAb engineering technology enables small changes to a protein structure that result in new mechanisms of therapeutic action. Its wholly owned development candidates include Vudalimab, XmAb819, XmAb808, and XmAb541. Candidates co-developed with partners include Plamotamab. Candidates advanced by partners include Xaluritamig (AMG 509), ASP2138, JNJ-9401, JNJ-1493, and Novartis XmAb undisclosed antibody candidate. Its cytokine drug candidates in clinical development consist of fbalropendekin alfa (XmAb306/RG6323), XmAb564, and XmAb662. Its other clinical-stage drug candidates consist of Obexelimab, AIMab7195 (XmAb7195), and Xpro1595. Vudalimab is a bispecific antibody that targets PD-1 and CTLA-4.

Contact Information

Headquarters
465 N. HALSTEAD ST., SUITE 200PASADENA, CA, United States 91107
Phone
626-305-5900
Fax
626-305-0350

Executives

President, Chief Executive Officer, Founder and Director
Bassil Dahiyat
Senior Vice President, Chief Financial Officer
Bart Cornelissen
Executive Vice President - Research, Chief Scientific Officer
John Desjarlais
Executive Vice President, Chief Development Officer
Nancy Valente
Senior Vice President, General Counsel, Corporate Secretary
Celia Eckert

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.5B
Revenue (TTM)
$133.6M
Shares Outstanding
69.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.65
EPS
$-2.90
Book Value
$10.96
P/E Ratio
-7.3x
Price/Sales (TTM)
11.0
Price/Cash Flow (TTM)
---
Operating Margin
-145.10%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.